Mirae Asset Global Investments Co. Ltd. Trims Stock Holdings in Henry Schein, Inc. (NASDAQ:HSIC)

Mirae Asset Global Investments Co. Ltd. trimmed its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 12.3% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 24,940 shares of the company’s stock after selling 3,491 shares during the period. Mirae Asset Global Investments Co. Ltd.’s holdings in Henry Schein were worth $1,888,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other hedge funds have also bought and sold shares of the business. Vanguard Group Inc. grew its stake in Henry Schein by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 15,331,533 shares of the company’s stock valued at $1,336,756,000 after buying an additional 214,846 shares in the last quarter. JPMorgan Chase & Co. grew its position in shares of Henry Schein by 1.1% during the 3rd quarter. JPMorgan Chase & Co. now owns 4,766,305 shares of the company’s stock valued at $353,898,000 after purchasing an additional 53,506 shares in the last quarter. American Century Companies Inc. grew its position in shares of Henry Schein by 7.3% during the 3rd quarter. American Century Companies Inc. now owns 4,719,088 shares of the company’s stock valued at $350,392,000 after purchasing an additional 322,649 shares in the last quarter. Morgan Stanley grew its position in shares of Henry Schein by 143.4% during the 4th quarter. Morgan Stanley now owns 2,337,890 shares of the company’s stock valued at $186,727,000 after purchasing an additional 1,377,207 shares in the last quarter. Finally, Macquarie Group Ltd. grew its position in shares of Henry Schein by 0.6% during the 2nd quarter. Macquarie Group Ltd. now owns 2,256,082 shares of the company’s stock valued at $173,427,000 after purchasing an additional 12,378 shares in the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

HSIC has been the subject of a number of recent analyst reports. TheStreet upgraded shares of Henry Schein from a “c+” rating to a “b-” rating in a research report on Monday, February 26th. Evercore ISI lifted their price objective on shares of Henry Schein from $79.00 to $83.00 and gave the stock an “in-line” rating in a report on Wednesday, February 28th. JPMorgan Chase & Co. lifted their price objective on shares of Henry Schein from $82.00 to $88.00 and gave the stock an “overweight” rating in a report on Wednesday, March 6th. Leerink Partnrs reaffirmed a “market perform” rating on shares of Henry Schein in a report on Monday, February 26th. Finally, SVB Leerink assumed coverage on shares of Henry Schein in a report on Monday, February 26th. They set a “market perform” rating and a $78.00 price objective for the company. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and five have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus price target of $81.09.

Henry Schein Price Performance

HSIC stock opened at $70.86 on Friday. Henry Schein, Inc. has a 1 year low of $60.01 and a 1 year high of $85.39. The company has a market cap of $9.10 billion, a P/E ratio of 22.50, a PEG ratio of 1.74 and a beta of 0.87. The firm has a 50-day moving average of $74.37 and a 200 day moving average of $72.47. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.67 and a quick ratio of 1.00.

Henry Schein (NASDAQ:HSIC) last released its quarterly earnings results on Tuesday, February 27th. The company reported $0.66 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.70 by ($0.04). Henry Schein had a return on equity of 14.03% and a net margin of 3.37%. The company had revenue of $3.02 billion during the quarter, compared to the consensus estimate of $3 billion. During the same period in the previous year, the company earned $1.21 earnings per share. Henry Schein’s quarterly revenue was down 10.5% on a year-over-year basis. On average, sell-side analysts forecast that Henry Schein, Inc. will post 5.07 EPS for the current year.

Insider Buying and Selling

In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other Henry Schein news, CEO Bradford C. Connett sold 6,430 shares of the firm’s stock in a transaction that occurred on Wednesday, March 20th. The shares were sold at an average price of $74.28, for a total transaction of $477,620.40. Following the completion of the transaction, the chief executive officer now owns 73,108 shares of the company’s stock, valued at $5,430,462.24. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Vice Chairman James P. Breslawski sold 2,907 shares of the firm’s stock in a transaction that occurred on Monday, March 18th. The shares were sold at an average price of $74.37, for a total transaction of $216,193.59. Following the sale, the insider now directly owns 209,562 shares of the company’s stock, valued at approximately $15,585,125.94. The disclosure for this sale can be found here. 1.14% of the stock is owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, physician practices, ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.